Antengene (FRA:722) Total Stockholders Equity: €77.90 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:722 Antengene Corp Ltd FRA:722
42 GF Score
Price €0.37
GF Value €0.15
! 6 Warning Signs
View Full Analysis

What is Antengene Total Stockholders Equity?

Antengene FRA:722 42 Total Stockholders Equity is €77.90 Mil as of Dec. 2025. GuruFocus rates FRA:722 with a GF Score™ of 42/100 and a GF Value™ of €0.15. The stock has 6 warning signs investors should review.

Antengene's Total Stockholders Equity for the quarter that ended in Dec. 2025 was €77.90 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Antengene's Book Value per Share for the quarter that ended in Dec. 2025 was €0.13. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Antengene's Debt-to-Equity for the quarter that ended in Dec. 2025 was 0.40.


Antengene  (FRA:722) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Antengene's Book Value per Share for the quarter that ended in Dec. 2025 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Antengene's Debt-to-Equity for the quarter that ended in Dec. 2025 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Antengene Total Stockholders Equity Related Terms


Antengene Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Antengene's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Antengene Total Stockholders Equity Chart

Antengene Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial 332.68 231.99 147.36 111.60 77.90

Antengene Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 127.24 111.60 92.53 77.90 116.87
FRA:722
42GF Score
Antengene Corp Ltd FRA:722
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of €77.90 Mil mean?
Antengene (FRA:722) has a Total Stockholders Equity of €77.90 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Antengene and its competitors.
Is Antengene's Total Stockholders Equity too high?
Antengene's current Total Stockholders Equity is €77.90 Mil. Overall, Antengene has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Antengene's Total Stockholders Equity compare to VRTX and REGN?
Antengene's Total Stockholders Equity of €77.90 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Antengene and its competitors. Antengene's current Total Stockholders Equity is €77.90 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Antengene stock overvalued right now?
Antengene (FRA:722) has a current Total Stockholders Equity of €77.90 Mil. The stock's GF Value™ is €0.15, compared to a current price of €0.37 — trading 148% above its estimated fair value. The current Total Stockholders Equity is €77.90 Mil. Antengene's overall GF Score™ is 42/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Antengene (FRA:722), the current Total Stockholders Equity is €77.90 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Antengene (FRA:722) Overvalued in 2026?

Based on GuruFocus' analysis, Antengene stock appears to be overvalued. The current stock price of €0.37 is trading 148% above its estimated GF Value™ of €0.15.

Key valuation signals for FRA:722:

  • Total Stockholders Equity: €77.90 Mil
  • GF Value™: €0.15 vs. price of €0.37 (148% above fair value)
  • GF Score™: 42/100 with 6 warning signs

No single metric tells the full story. See the FRA:722 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Antengene Business Description

Other Exchanges 06996:Hong Kong
Address 1065 West Zhongshan Road, Suites 1206-1209, Block B, Zhongshan SOHO Plaza, Changning District, Shanghai, CHN
Antengene Corp Ltd is a clinical-stage biopharmaceutical company focused on oncology medicines. The company produces drugs such as selinexor, eltanexor, verdinexor, and other products. It also engages in the discovery, development, manufacturing, and commercialization of first-in-class therapeutics for the treatment of hematologic malignancies and solid tumors. Geographically, it operates in the Chinese Mainland, Hong Kong, Macao and Taiwan and Overseas.
42GF Score

Get the complete analysis for FRA:722

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.37
Price
€0.15
GF Value